Next-generation sequencing technologies: Breaking the sound barrier of human genetics

Mutagenesis

Volumn 29, Issue 5, 2014, Pages 303-310

  Bahassi, El Mustapha ^a   Stambrook, Peter J ^b  

^a Brain Tumor Center at UC Neuroscience Institute   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGY; DNA SEQUENCE; GENOTYPE; HIGH THROUGHPUT SEQUENCING; HUMAN; HUMAN GENOME; MEDICAL GENETICS; PHENOTYPE; PROCEDURES; TRENDS;

COMPUTATIONAL BIOLOGY; GENETICS, MEDICAL; GENOME, HUMAN; GENOTYPE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; PHENOTYPE; SEQUENCE ANALYSIS, DNA;

EID: 84906812180     PISSN: 02678357     EISSN: 14643804     Source Type: Journal    
DOI: 10.1093/mutage/geu031     Document Type: Review

References (72)

1. Hayden, E. C. (2014) Is the $1, 000 genome for real? Nature News, January 15.
2. Robertson, J. A. (2003) The $1000 genome: ethical and legal issues in whole genome sequencing of individuals. Am. J. Bioeth., 3, W-IF1.
3. Caulfield, T., McGuire, A. L., Cho, M., et al. (2008) Research ethics recommendations for whole-genome research: consensus statement. PLoS Biol., 6, e73.
4. Green, E. D. and Guyer, M. S. (2011) Charting a course for genomic medicine from base pairs to bedside. Nature, 470, 204-213.
5. Tabor, H. K., Berkman, B. E., Hull, S. C. and Bamshad, M. J. (2011) Genomics really gets personal: how exome and whole genome sequencing challenge the ethical framework of human genetics research. Am. J. Med. Genet. A, 155, 2916-2924.
6. Bentley, D. R., Balasubramanian, S., Swerdlow, H. P., et al. (2008) Accurate whole human genome sequencing using reversible terminator chemistry. Nature, 456, 53-59.
7. McKernan, K. J., Peckham, H. E., Costa, G. L., et al. (2009) Sequence and structural variation in a human genome uncovered by short-read, massively parallel ligation sequencing using two-base encoding. Genome Res., 19, 1527-1541.
8. Margulies, M., Egholm, M., Altman, W. E., et al. (2005) Genome sequencing in microfabricated high-density picolitre reactors. Nature, 437, 376-380.
9. Shendure, J. and Ji, H. (2008) Next-generation DNA sequencing. Nat. Biotechnol., 26, 1135-1145.
10. Drmanac, R., Sparks, A. B., Callow, M. J., et al. (2010) Human genome sequencing using unchained base reads on self-assembling DNA nanoarrays. Science, 327, 78-81.
11. Ee, R., Lim, Y. L., Yin, W. F. and Chan, K. G. (2014) De Novo assembly of the quorum-sensing Pandoraea sp. strain RB-44 complete genome sequence using PacBio single-molecule real-time sequencing technology. Genome Announc., 2, e00245-14.
12. Cebula, A., Seweryn, M., Rempala, G. A., et al. (2013) Thymus-derived regulatory T cells contribute to tolerance to commensal microbiota. Nature, 497, 258-262.
13. Eisenstein, M. (2012) The battle for sequencing supremacy. Nat. Biotechnol., 30, 1023-1026.
14. Wang, Z., Gerstein, M. and Snyder, M. (2009) RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet., 10, 57-63.
15. Wold, B. and Myers, R. M. (2008) Sequence census methods for functional genomics. Nat. Methods, 5, 19-21.
16. Petrosino, J. F., Highlander, S., Luna, R. A., Gibbs, R. A. and Versalovic, J. (2009) Metagenomic pyrosequencing and microbial identification. Clin. Chem., 55, 856-866.
17. Lipson, D., Raz, T., Kieu, A., et al. (2009) Quantification of the yeast transcriptome by single-molecule sequencing. Nat. Biotechnol., 27, 652-658.
18. Ozsolak, F. Platt, A. R., Jones, D. R., et al. (2009) Direct RNA sequencing. Nature, 461, 814-818.
19. Park, P. J. (2009) ChIP-seq: advantages and challenges of a maturing technology. Nat. Rev. Genet., 10, 669-680.
20. Berglund, E. C., Kiialainen, A. and Syvänen, A. C. (2011) Next-generation sequencing technologies and applications for human genetic history and forensics. Investig. Genet., 2, 23.
21. Quail, M. A., Smith, M., Coupland, P., Otto, T. D., Harris, S. R., Connor, T. R., Bertoni, A., Swerdlow, H. P. and Gu, Y. (2012) A tale of three next generation sequencing platforms: comparison of Ion Torrent, Pacific Biosciences and Illumina MiSeq sequencers. BMC Genomics, 13, 341.
22. Pop, M. and Salzberg, S. L. (2008) Bioinformatics challenges of new sequencing technology. Trends Genet., 24, 142-149.
23. Trapnell, C. and Salzberg, S. L. (2009) How to map billions of short reads onto genomes. Nat. Biotechnol., 27, 455-457.
24. Chaisson, M. J., Brinza, D. and Pevzner, P. A. (2009) De novo fragment assembly with short mate-paired reads: does the read length matter? Genome Res., 19, 336-346.
25. Gogol-Döring, A. and Chen, W. (2012) An overview of the analysis of next generation sequencing data. Methods Mol. Biol., 802, 249-257.
26. Li, H., Ruan, J. and Durbin, R. (2008) Mapping short DNA sequencing reads and calling variants using mapping quality scores. Genome Res., 18, 1851-1858.
27. Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R.; 1000 Genome Project Data Processing Subgroup. (2009) The Sequence Alignment/Map format and SAMtools. Bioinformatics, 25, 2078-2079.
28. Li, R., Li, Y., Kristiansen, K. and Wang, J. (2008) SOAP: short oligonucleotide alignment program. Bioinformatics, 24, 713-714.
29. Chen, K., Wallis, J. W., McLellan, M. D., et al. (2009) BreakDancer: an algorithm for high-resolution mapping of genomic structural variation. Nat. Methods, 6, 677-681.
30. Koboldt, D. C., Chen, K., Wylie, T., Larson, D. E., McLellan, M. D., Mardis, E. R., Weinstock, G. M., Wilson, R. K. and Ding, L. (2009) VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics, 25, 2283-2285.
31. Milne, I., Bayer, M., Cardle, L., Shaw, P., Stephen, G., Wright, F. and Marshall, D. (2010) Tablet - next generation sequence assembly visualization. Bioinformatics, 26, 401-402.
32. Carver, T., Böhme, U., Otto, T. D., Parkhill, J. and Berriman, M. (2010) BamView: viewing mapped read alignment data in the context of the reference sequence. Bioinformatics, 26, 676-677.
33. Fiume, M., Williams, V., Brook, A. and Brudno, M. (2010) Savant: genome browser for high-throughput sequencing data. Bioinformatics, 26, 1938-1944.
34. Rutherford, K., Parkhill, J., Crook, J., Horsnell, T., Rice, P., Rajandream, M. A. and Barrell, B. (2000) Artemis: sequence visualization and annotation. Bioinformatics, 16, 944-945.
35. Kent, W. J., Sugnet, C. W., Furey, T. S., Roskin, K. M., Pringle, T. H., Zahler, A. M. and Haussler, D. (2002) The human genome browser at UCSC. Genome Res., 12, 996-1006.
36. Robinson, J. T., Thorvaldsdóttir, H., Winckler, W., Guttman, M., Lander, E. S., Getz, G. and Mesirov, J. P. (2011) Integrative genomics viewer. Nat. Biotechnol., 29, 24-26.
37. Krzywinski, M., Schein, J., Birol, I., Connors, J., Gascoyne, R., Horsman, D., Jones, S. J. and Marra, M. A. (2009) Circos: an information aesthetic for comparative genomics. Genome Res., 19, 1639-1645.
38. Furgason, J. M., Li, W., Milholland, B., et al. (2014) Whole genome sequencing of glioblastoma multiforme identifies multiple structural variations involved in EGFR activation. Mutagenesis doi:10.1093/mutage/geu026.
39. Roberts, R. J., Carneiro, M. O. and Schatz, M. C. (2013) The advantages of SMRT sequencing. Genome Biol., 14, 405.
40. Ribeiro, F. J., Przybylski, D., Yin, S., et al. (2012) Finished bacterial genomes from shotgun sequence data. Genome Res., 22, 2270-2277.
41. Koren, S., Harhay, G. P., Smith, T. P., Bono, J. L., Harhay, D. M., Mcvey, S. D., Radune, D., Bergman, N. H. and Phillippy, A. M. (2013) Reducing assembly complexity of microbial genomes with single-molecule sequencing. Genome Biol., 14, R101.
42. Maron, L. G., Guimarães, C. T., Kirst, M., et al. (2013) Aluminum tolerance in maize is associated with higher MATE1 gene copy number. Proc. Natl. Acad. Sci. USA, 110, 5241-5246.
43. Koren, S., Schatz, M. C., Walenz, B. P., et al. (2012) Hybrid error correction and de novo assembly of single-molecule sequencing reads. Nat. Biotechnol., 30, 693-700.
44. Vilfan, I. D., Tsai, Y. C., Clark, T. A., Wegener, J., Dai, Q., Yi, C., Pan, T., Turner, S. W. and Korlach, J. (2013) Analysis of RNA base modification and structural rearrangement by single-molecule real-time detection of reverse transcription. J. Nanobiotechnol., 11, 8.
45. Uemura, S., Aitken, C. E., Korlach, J., Flusberg, B. A., Turner, S. W. and Puglisi, J. D. (2010) Real-time tRNA transit on single translating ribosomes at codon resolution. Nature, 464, 1012-1017.
46. Saletore, Y., Meyer, K., Korlach, J., Vilfan, I. D., Jaffrey, S. and Mason, C. E. (2012) The birth of the Epitranscriptome: deciphering the function of RNA modifications. Genome Biol., 13, 175.
47. Braggio, E., Egan, J. B., Fonseca, R. and Stewart, A. K. (2013) Lessons from next-generation sequencing analysis in hematological malignancies. Blood Cancer J., 3, e127.
48. Mwenifumbo, J. C. and Marra, M. A. (2013) Cancer genome-sequencing study design. Nat. Rev. Genet., 14, 321-332.
49. Shyr, D. and Liu, Q. (2013) Next generation sequencing in cancer research and clinical application. Biol. Proced. Online, 15, 4.
50. Simon, R. and Roychowdhury, S. (2013) Implementing personalized cancer genomics in clinical trials. Nat. Rev. Drug Discov., 12, 358-369.
51. Ulahannan, D., Kovac, M. B., Mulholland, P. J., Cazier, J. B. and Tomlinson, I. (2013) Technical and implementation issues in using nextgeneration sequencing of cancers in clinical practice. Br. J. Cancer, 109, 827-835.
52. Bras, J., Guerreiro, R. and Hardy, J. (2012) Use of next-generation sequencing and other whole-genome strategies to dissect neurological disease. Nat. Rev. Neurosci., 13, 453-464.
53. Foo, J. N., Liu, J. J. and Tan, E. K. (2012) Whole-genome and whole-exome sequencing in neurological diseases. Nat. Rev. Neurol., 8, 508-517.
54. Mok, T. S., Wu, Y. L., Thongprasert, S., et al., (2009) Gefitinib or carboplatin- paclitaxel in pulmonary adenocarcinoma. N. Engl. J. Med., 361, 947-957.
55. Chapman, P. B., Hauschild, A., Robert, C., et al., (2011) Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med., 364, 2507-2516.
56. The Cancer Genome Atlas Research Network (2012a) Comprehensive genomic characterization of squamous cell lung cancers. Nature, 489, 519-525.
57. The Cancer Genome Atlas Research Network (2012b) Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487, 330-337.
58. The Cancer Genome Atlas Research Network (2012c) Comprehensive molecular portraits of human breast tumours. Nature, 490, 61-70.
59. Phillips, H. S., Kharbanda, S., Chen, R., et al. (2006) Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell, 9, 157-173.
60. Verhaak, R. G., Hoadley, K.A., Purdom, E., et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell, 17, 98-110.
61. Chapman, P. B., Hauschild, A., Robert, C., et al.; BRIM-3 Study Group. (2011). Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N. Engl. J. Med., 364, 2507-2516.
62. Singh, S., Singh, M., Mak, I. W., Turcotte, R. and Ghert, M. (2012) Investigation of FGFR2-IIIC signaling via FGF-2 ligand for advancing GCT stromal cell differentiation. PLoS One, 7, e46769.
63. Brennan, C. W., Verhaak, R. G., McKenna, A., et al. (2013) The somatic genomic landscape of glioblastoma. Cell, 157, 753.
64. Salkeni, M. A., Zarzour, A., Ansay, T. Y., McPherson, C. M., Warnick, R. E., Rixe, O. and Bahassi, el M. (2013) Detection of EGFRvIII mutant DNA in the peripheral blood of brain tumor patients. J. Neurooncol., 115, 27-35.
65. Diehl, F., Schmidt, K., Choti, M. A., et al. (2008) Circulating mutant DNA to assess tumor dynamics. Nat. Med., 14, 985-990.
66. Morgan, S. R., Whiteley, J., Donald, E., Smith, J., Eisenberg, M. T., Kallam, E. and Kam-Morgan, L. (2012) Comparison of KRAS mutation assessment in tumor DNA and circulating free DNA in plasma and serum samples. Clin. Med. Insights Pathol., 5, 15-22.
67. Forshew, T., Murtaza, M., Parkinson, C., et al. (2012) Noninvasive identification and monitoring of cancer mutations by targeted deep sequencing of plasma DNA. Sci. Transl. Med., 4, 136ra68.
68. Dawson, S. J., Tsui, D. W., Murtaza, M., et al. (2013) Analysis of circulating tumor DNA to monitor metastatic breast cancer. N. Engl. J. Med., 368, 1199-1209.
69. Bidard, F. C., Madic, J., Mariani, P., et al. (2014) Detection rate and prognostic value of circulating tumor cells and circulating tumor DNA in metastatic uveal melanoma. Int. J. Cancer, 134, 1207-1213.
70. Murtaza, M., Dawson, S. J., Tsui, D. W., Gale, D., Forshew, T., Piskorz, A. M., Parkinson, C., Chin, S. F., Kingsbury, Z., et al. (2013) Non-invasive analysis of acquired resistance to cancer therapy by sequencing of plasma DNA. Nature, 497, 108-112.
71. Diaz, L. A., Jr, Sausen, M., Fisher, G. A. and Velculescu, V. E. (2013) Insights into therapeutic resistance from whole-genome analyses of circulating tumor DNA. Oncotarget, 4, 1856-1857.
72. Leary, R. J. Sausen, M., Kinde, I., et al. (2012) Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci. Transl. Med., 4, 162ra154.